Congenital and Pediatric Retinal Diseases



Congenital and Pediatric Retinal Diseases


Nikolas J.S. London

Richard S. Kaiser



Retinopathy of Prematurity

Retinopathy of prematurity (ROP) is a proliferative retinopathy of premature, low-birth-weight infants.


Epidemiology and Etiology



  • Despite recent advances, ROP remains a leading cause of visual loss in children. Infants born at less than 30 weeks gestation and/or those with a birth weight of 1500 g or less should be examined by indirect ophthalmoscopy. Infants who are born weighing 1000 g or less are at particularly high risk of developing severe ROP.


  • The retinal vasculature of infants born prematurely has not completed its growth to the ora serrata. The developing vasculature is susceptible to capillary endothelial cytotoxicity. Pre-existing vessels are damaged and neovascularization develops off the surface of the retina. Continued growth and contraction of fibrovascular tissue may lead to retinal detachment.


History



  • The critical components of the history are the birth weight, the gestational age at birth, the current postmenstrual age, and the current chronological age. One should also inquire regarding the use of mechanical ventilation and/or supplemental oxygen, the length of stay in the neonatal ICU, blood transfusions, the presence of any bronchodysplasia or hyaline membrane disease. Pregnancy history, maternal health, and family history are also often obtained.


Diagnostic Evaluation



  • Careful examination of neonates with indirect ophthalmoscopy in the intensive care nursery or at discharge is essential to detect ROP at a stage where treatment can be applied.


  • Examinations should start at 31 weeks postmenstrual age or by 4 weeks chronological
    age, based on gestational age, and should continue every 1 to 3 weeks, until one of the following occurs:



    • There is vascularization of zone III without prior zone I or II disease.


    • Postmenstrual age 45 weeks is achieved with no prethreshold ROP.


    • The retina is completely vascularized.


    • There is total regression of treated ROP.


Important Clinical Signs



  • The posterior segment signs of ROP follow a progression of increasing severity that were classified according to the International Classification of ROP (ICROP).


  • First the location of the disease is determined, then the stage of severity, and finally the extent of that stage is noted (Table 7-1, Figs. 7-1 to 7-5).


Associated Clinical Signs



  • “Plus” disease denotes increased severity. When an eye has dilation and tortuosity of the retinal vessels in the posterior pole, then it is said to have plus disease and has a poorer prognosis (Fig. 7-6). When vascularization is only present in zone I and there is plus disease, then a very poor prognosis exists because of the risk of rapid progression (“rush” disease).


  • “Threshold” disease is a level of ROP at which it is predicted that there is a 50% chance of progression to retinal detachment without treatment. It was defined in the CRYO-ROP study as 5 contiguous clock hours of extraretinal fibrovascular proliferation (ERFP) with plus disease or 8 accumulated clock hours of ERFP with plus disease (Fig. 7-7). When threshold disease is reached, treatment is recommended. In addition, current guidelines indicate treatment within 72 hours for the following clinical situations:








    Table 7-1. International Classification of Retinopathy of Prematurity (ICROP)








































    Location
    Zone I Posterior circle of retina centered on the optic nerve with a radius of twice the disc-fovea distance
    Zone II Circular area of retina from the edge of zone I to the nasal ora serrata
    Zone III Remaining temporal crescent of retina
    Extent
    Number of clock hours or 30-degree sectors involved
    Severity
    Stage 1 Demarcation line between posterior vascularized retina and anterior avascular retina
    Stage 2 Demarcation line with height, width, and volume (ridge)
    Stage 3 Ridge with extraretinal fibrovascular proliferation (ERFP); may be mild, moderate, or severe
    Stage 4 Subtotal retinal detachment
    4A Extrafoveal
    4B Involving the fovea
    Stage 5 Total retinal detachment; always funnel-shaped
    Open anteriorly, open posteriorly
    Open anteriorly, narrow posteriorly
    Narrow anteriorly, open posteriorly
    Narrow anteriorly, narrow posteriorly



    • Zone I, any stage, with plus disease



    • Zone I, stage III, with or without plus disease


    • Zone II, stage II or III, with plus disease


  • Occasionally neovascular tissue may form buds of vascular proliferation behind the ridge or demarcation line. These lesions are called “popcorn” because of their similarity to popped corn (see Fig. 7-3A). These lesions do not carry any prognostic significance unless they are a part of ERFP at the advancing border of vascularization. Vitreous hemorrhage and preretinal hemorrhage can occasionally be seen in eyes with severe ERFP.


  • In early cicatricial ROP (after resolution of the acute phase) there may be a variety of tractional complications. A hallmark finding of regressed cicatricial ROP is temporal retinal dragging (Fig. 7-8).


  • After regression of ROP, either spontaneously or with treatment, several associated abnormalities may occur.



    • Myopia


    • Astigmatism


    • Strabismus


    • Amblyopia


    • Cataract


    • Glaucoma


    • Macular ectopia


    • Retinal fold


    • Retinal detachment—rhegmatogenous or exudative


Differential Diagnosis



  • The clinical setting usually aids in the diagnosis of ROP. Infants are born prematurely and are of low birth weight with a history of oxygen exposure.


  • Differential diagnosis depends on the stage of the disease. In less severe ROP, conditions that cause peripheral retinal vascular changes and retinal dragging should be considered.



    • Familial exudative vitreoretinopathy (FEVR)


    • Incontinentia pigmenti (Bloch–Sulzberger syndrome)


    • X-linked retinoschisis


    • Norrie’s disease


  • In advanced cicatricial ROP, the differential diagnosis is that of retinal detachment or a white pupillary reflex, or both.



    • Cataract


    • FEVR


    • Persistent fetal vasculature (PFV)


    • Ocular toxocariasis


    • Intermediate uveitis


    • Coats’ disease


    • Retinoblastoma


    • Vitreous hemorrhage


    • Retinal detachment


    • Endophthalmitis


Prognosis and Management



  • The majority of infants who develop ROP undergo spontaneous regression (85%). However, 7% of infants weighing less than 1251 g at birth will develop threshold ROP.


  • Cryotherapy to the anterior avascular zone (Fig. 7-9) has been shown to reduce the likelihood of an unfavorable outcome (retinal fold through zone I, retinal detachment, or retrolental fibroplasia) by 50% in the cryotherapy for ROP Study. Visual results are commensurately improved.



  • Laser photocoagulation delivered with an indirect ophthalmoscope to the anterior avascular zone has virtually replaced cryotherapy for threshold ROP (Fig. 7-10). Laser burns should be spaced evenly, approximately one-half burn width apart, with particular attention to the most posterior avascular retina. Better visual outcomes have been achieved with laser treatment.


  • Antiangiogenic injection therapy for ROP is being investigated, with early reports of success. Bevacizumab eliminates the angiogenic threat of ROP is a randomized trial comparing intravitreal bevacizumab to conventional laser treatment.


  • More advanced stages of ROP (stages 4 and 5 retinal detachment) can be treated with scleral buckling or vitrectomy, or both. The prognosis for visual recovery after retinal detachment remains poor.







Figure 7-1. Retinopathy of prematurity (ROP). Schematic diagram of division of fundus into zones for defining location of involvement with ROP.






Figure 7-2. ROP, stage 2. The demarcation line (arrow) between posterior vascularized and anterior avascular retina is elevated as a ridge.







Figure 7-3. ROP, stage 3. A. The ridge has fibrovascular tissue and is elevated off the surface of the retina (extraretinal fibrovascular proliferation, or ERFP). This is an example of severe stage 3 ROP. Buds of vascular proliferation behind the ridge are “popcorn” lesions (arrow). B. Fluorescein angiogram from same patient as in A showing intense hyperfluorescence from vascular proliferative tissue in region of ridge.







Figure 7-4. ROP, stage 5. Eye with shallow total retinal detachment. Note loss of choroidal detail due to shallow subretinal fluid accumulation in posterior pole.






Figure 7-5. ROP, stage 5. This eye has a total tractional retinal detachment due to severe fibrous proliferation with contraction of the fibrous tissue. Note the vascularized tissue behind the clear lens.







Figure 7-6. ROP, plus disease. Dilation and tortuosity of vessels in the posterior pole denotes progressive disease and is known as “plus” disease.






Figure 7-7. ROP, threshold disease. Schematic diagram of threshold disease according to the Cryotherapy for Retinopathy of Prematurity Study Group. Reprinted by permission of American Medical Association from Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy of retinopathy of prematurity: Preliminary results. Arch Ophthalmol 1988;106:474.







Figure 7-8. ROP. Severe dragging of the temporal retina with vascular straightening (arrow) is a late cicatricial complication of ROP. Compare with familial exudative vitreoretinopathy, in Figure 7-18A.







Figure 7-9. ROP, cryotherapy. A. The arrow points to the anterior avascular zone where cryotherapy will be placed for threshold ROP. B. Late postoperative appearance of cryotherapy. Note regression of extraretinal fibrovascular proliferation.







Figure 7-10. ROP. A. Preoperative appearance of an eye with posterior threshold ROP. B. Late postoperative appearance after laser photocoagulation. Note regression of extraretinal fibrovascular proliferation.



Incontinentia Pigmenti

Incontinentia pigmenti, or Bloch–Sulzberger syndrome, is a rare X-linked dominant condition that includes ocular, skin, central nervous system, skeletal, dental, and other systemic abnormalities.


Epidemiology and Etiology



  • The pathogenesis of incontinentia pigmenti is unknown. It is an X-linked dominant condition that is usually lethal in males and thus usually only seen in female infants. However, an affected male with Klinefelter syndrome (XXY) or a genetic mosaicism may survive.


History



  • Characteristic skin changes usually start days after birth, with ophthalmic findings developing in infancy or even later in life.


Important Clinical Signs



  • Approximately one-third of infants with incontinentia pigmenti have ocular findings. Fundus abnormalities include dilated, tortuous retinal vessels, peripheral retinal capillary nonperfusion with arteriovenous anastomoses and neovascularization (Figs. 7-11 and 7-12), foveal hypoplasia, branch artery occlusions, neovascularization of the disc, retinal dragging, tractional and rhegmatogenous retinal detachments, retinal folds, vitreous hemorrhage, and optic disc pallor.


  • The ocular abnormalities are often extremely asymmetric.


Associated Clinical Signs

Jul 14, 2016 | Posted by in OPHTHALMOLOGY | Comments Off on Congenital and Pediatric Retinal Diseases

Full access? Get Clinical Tree

Get Clinical Tree app for offline access